CTRI/2015/01/005442招募中未知
Effect of low dose cyclophosphamide pulse therapy on the skin sclerosis in scleroderma - CPMSS
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients of systemic sclerosis, satisfying the ACR criteria for systemic sclerosis attending the Out Patient, Department of Dermatology in Calicut Medical College.
排除标准
- •1.Patients who have not given the consent to be a part of the study
- •2.Pregnant females
- •3.Patients with major organ involvement
- •4.Those with previous history of use of cyclophosphamide, prednisolone or other immunosuppressive agents
研究者
相似试验
进行中（未招募）
2 期
Short treatment with the drug cyclophosphamide in bowel cancerStage II-IVA diagnosed colorectal cancerBowel cancerCancerISRCTN12508004Cardiff University500
招募中
2 期
A Phase II dose escalation study of cyclophosphamide in haematopoietic stem cell transplantation in severe systemic sclerosis patients unfit for standard dose cyclophosphamide.systemic sclerosisAutoimmune disorderACTRN12617000216314St Vincent's Hospital Sydney15
进行中（未招募）
1 期
Graft-versus-host response after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantatioWomen and men with a hematologic malignancy for which a reduced-intensity conditioning allo-SCT is indicatedMedDRA version: 19.0Level: PTClassification code 10053239Term: Prophylaxis against graft versus host diseaseSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-002129-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)88
招募中
2 期
Cyclophosphamide to treat CNS TB related proliferative arachnoiditis not responding to usual medicationsIn our Department, we tried cyclophosphamide in four patients after consent, and found remarkable improvement in all of them. In order to test this, a randomized controlled trial is needed.CTRI/2020/11/029276All India Institute of Medical Sciences New Delhi
进行中（未招募）
不适用
Cyclophosphamide and Dexamethasone in combination with Ixazomib (ICD), in relpased or refractory multiple myeloma patients.Relasped and Refractory Mulitple MyelomaMedDRA version: 18.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2014-004511-36-GBniversity Of Leeds250